Neonatal Jaundice. Neonatal Jaundice, Unspecified
Conditions
Interventions
Intervention 1: Control group only treated with photo therapy. Intervention 2: Intervention group one, infant received Bilikatermana 5 drops per kg of body weight three times a day in addition to the
Early detection
Treatment - Drugs
Control group only treated with photo therapy
Intervention group one, infant received Bilikatermana 5 drops per kg of body weight three times a day in addition to the phototherapy
Group two, infant received Bilineaster 5 drops per kg of body weight three times a day in addition to the phototherapy
Group three, infant and her/his mother received Bilicatermana 2 drops per kg of body weight three times a day in addition to the phototherapy (infant)
Group four, infant and her/his mother received Bilineaster 2 drops per kg of body weight three times a day in addition to the phototherapy (infant)
Group five, infants mother received Bilikatermana 5 drops per kg of body weight three times a day in addition to the phototherapy (infant)
Group six, infants mother received Bilineaster 5 drops per kg of body weight three times a day in addition to the phototherapy (infant)
Sponsors
Dezful University Of Medical Sciences
Eligibility
Sex/Gender
All
Age
2 Days to 14 Days
Inclusion criteria
Inclusion criteria: Inclusion criteria: Healthy term breast-fed infants weighing 2.5 to 4 Kg after 36 hours until 14 days developed jaundice and photo therapy indicated. Exclusion criteria: per-and post term infants; formula feeding; the presence of any malformations and associated diseases such as sepsis; weighing less than 2.5 and more than 4 kg; neonates developed jaundice after 14 days who need Intensive photo therapy or exchange; ABO or RH incompatibility; presence direct hyper bilirubinemia.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bilirubin. Timepoint: On arrival at the hospital, 12, 24, 48, 72 hours after it. Method of measurement: Bailey Test milligrams per deciliter. | — |
Secondary
| Measure | Time frame |
|---|---|
| Bilirubin. Timepoint: 12, 24, 48, 72 hours after it. Method of measurement: Bailey Test milligrams per deciliter. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamidreza Aghababaeian
Dezful University Of Medical Sciences, Dezful, Iran
Outcome results
None listed